Incyte
5
22M
5
0.16
3
- Areas of investment
Summary
Incyte is the famous Corporate Investor, which was founded in 1991. The company was established in North America in United States. The main office of represented Corporate Investor is situated in the Wilmington.
Among the most popular fund investment industries, there are Pharmaceutical, E-Learning. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Among the most popular portfolio startups of the fund, we may highlight Iconix Biosciences. Besides, a startup needs to be aged 4-5 years to get the investment from the fund.
The standard case for the fund is to invest in rounds with 4-5 partakers. Despite the Incyte, startups are often financed by Prelude Trust, Avlar BioVentures. The meaningful sponsors for the fund in investment in the same round are Wilson Sonsini Goodrich & Rosati, The Cambridge Gateway Fund, Roche Venture Fund. In the next rounds fund is usually obtained by IVP (Institutional Venture Partners).
Comparing to the other companies, this Incyte performs on 38 percentage points more the average number of lead investments. The usual things for fund are deals in the range of 10 - 50 millions dollars. The top amount of exits for fund were in 2007. The important activity for fund was in 2002. The fund is constantly included in less than 2 investment rounds annually.
Investments analytics
Analytics
- Total investments
- 5
- Lead investments
- 0
- Exits
- 3
- Rounds per year
- 0.16
- Investments by industry
- Medical (3)
- Biotechnology (3)
- Life Science (2)
- Therapeutics (2)
- Pharmaceutical (1) Show 4 more
- Investments by region
-
- United States (4)
- United Kingdom (1)
- Peak activity year
- 2001
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 23
- Avg. valuation at time of investment
- 3M
- Group Appearance index
- 0.60
- Avg. company exit year
- 11
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| GeneEd | 26 Jun 2000 | Information Technology, E-Learning, Life Science | Seed | 2M | United States, California, San Francisco |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.